Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Use of altered informed consent in pragmatic clinical research.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Newer therapies for multiple sclerosis.
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
Stable biomarker for plastic microglia.
Next-Generation Sequencing Identifies MicroRNAs that Associate with Pathogenic Autoimmune Neuroinflammation in Rats.
Determinants of disability in multiple sclerosis: an immunological and MRI study.
A preliminary study of functional imaging upon placebo analgesia in progressive multiple sclerosis.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
The best clinical paper on multiple sclerosis in 2014.
Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one - Time administration of encephalitogenic T cells.
Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up.
Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.
Factors affecting employment among informal caregivers assisting people with multiple sclerosis.
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis: A Case Series.
Dissecting the role of E2 protein domains on alphavirus pathogenicity.
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
Literature Commentary.

Pages